About
Maruho Israel Innovation Fund (MII Fund), was founded by a Japanese-Israeli team of venture and R&D experts jointly with Maruho, a Japanese dermatology company, and the fund's strategic partner. The fund was formed with the vision of integrating Israeli innovation capabilities with Japanese corporate expertise. The fund brings along not only investment but also R&D, expertise, market validation, and the necessary know-how required for advancing products to market. MII invests in dermatology related technologies across stages seed to growth and sectors pharma, biotech, medical device, digital health, and cosmetics. The fund has also created an excellence center for dermatological development, MII Labs , a wholly owned subsidiary of the fund, where experts in dermatology and topical development work use state of the art infrastructure to work with the Funds portfolio companies on their existing as well as next generation technologies. The lab enables MII to seed new companies and to help the portfolio companies in reaching clinical proof of concept.
Portfolio
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary investment focus of Maruho Israel Innovation Fund?
- Maruho Israel Innovation Fund (MII Fund) primarily invests in dermatology-related technologies across various stages (seed to growth) and sectors including pharma, biotech, medical device, digital health, and cosmetics.
- When was Maruho Israel Innovation Fund founded and by whom?
- Maruho Israel Innovation Fund was founded in 2018 by a Japanese-Israeli team of venture and R&D experts, jointly with Maruho, a Japanese dermatology company, and its strategic partner. The founders include Eran Perry, Doron Friedman, Masanobu Ogawa, and Junichi Hamada.
- What unique value proposition does Maruho Israel Innovation Fund offer to its portfolio companies beyond investment?
- Beyond investment, Maruho Israel Innovation Fund provides R&D expertise, market validation, and know-how for advancing products to market. It also operates MII Labs, an excellence center for dermatological development, which works with portfolio companies on existing and next-generation technologies.
- Can you name some notable portfolio companies of Maruho Israel Innovation Fund and their investment dates?
- Maruho Israel Innovation Fund invested $200,000,000 as a lead investor in Upstream Bio in June 2022, and $5,000,000 as a lead investor in Follicle Pharma in January 2021. For a full list, please refer to startupim data.
- What is the geographic focus of Maruho Israel Innovation Fund's operations?
- Maruho Israel Innovation Fund has its headquarters in Rehovot, Israel, and an additional office in Leverkusen, Germany.
- What is the earliest recorded investment by Maruho Israel Innovation Fund?
- According to startupim data, Maruho Israel Innovation Fund's earliest recorded investment was in TPCera in July 2018, with an amount of $3,000,000.
- In which investment stages does Maruho Israel Innovation Fund participate?
- Maruho Israel Innovation Fund invests across various stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- What is the typical investment range for Maruho Israel Innovation Fund?
- Maruho Israel Innovation Fund's investment range is between $3 million and $200 million.